Anastrozole(Arimidex)

Anastrozole(Arimidex)

CAS No： 120511-73-1

Molecular formula： 120511-73-1

Molecular weight： 293.37

Appearance： White powder.

Assay： 99%

Delivery time： 5-7 business days door-to-door

Minimum order： 1g

Supply ability： 10kg per mouth

Quality standard： USP 35                                                                                                                                     Product details:

Anastrozole is an aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for

metastasis in both pre and postmenopausal women. The severity of breast cancer is increased by estrogen, as sexhormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen.

The trial suggested that anastrozole is the preferred medical therapy for Postmenopausal women with localized breast cancer that is estrogen receptor (ER) positive.

Three azole potent selective aromatase inhibitors, which inhibit rely on aromatase cytochrome P -450 to block 

estrogen biosynthesis, and the main factors of estrogen to stimulate breast cancer cell growth. It can treat breast  cancer, especially suitable for those who relapse after treatment with hormone auxiliary advanced breast cancer after menopause women.